Closed reduction of colles fractures: comparison of manual manipulation and finger-trap traction: a prospective, randomized study.
S A Earnshaw, A Aladin, S Surendran...
https://pubmed.ncbi.nlm.nih.gov/11886903/Actively Recruiting
Led by Oslo University Hospital · Updated on 2026-08-12
212
Participants Needed
1
Research Sites
25 weeks
Total Duration
Researchers are studying radiological criteria to determine if dorsally displaced distal radius fractures can remain stable without surgery after closed reduction in patients aged 18 to 65 years. This study focuses on improving decision-making for surgery by identifying which fractures maintain their position after treatment with casting, considering factors such as osteoporosis and fracture types. The trial aims to reduce unnecessary surgeries that can cause complications and stress for patients while also addressing socio-economic concerns related to overtreatment. Participants with dorsally displaced distal radius fractures will undergo closed reduction and casting. X-rays will be taken before and after reduction, along with CT scans the day after reduction. Follow-up X-rays will be conducted at 6-8 days, with additional checks if slight redislocation occurs, and final X-rays will be performed after 3 months. The study will evaluate various radiological factors, including dorsal dislocation, ulnar variance, volar cortex positioning, and comminution, to determine fracture stability. Participants will have several visits for imaging and assessment of fracture position over 3 months. Experienced doctors will review X-rays and CT scans to measure fracture stability and decide if surgery is needed. The study will also record complications like complex regional pain syndrome and malunion surgeries. The primary outcome is radiological criteria at 3 months, with secondary outcomes including CT criteria and the influence of osteoporosis in patients aged 50-65. Total participation lasts about 3 months with periodic follow-up visits.
CONDITIONS
Radiological Criteria for Instability in Distal Radius Fractures
L
Lene B. Solberg, PhD MD
I
Ingrid Oftebro, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Oslo University Hospital
Lead Sponsor
Bergesenstiftelsen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants receive X-rays before and after closed reduction of the fracture, and a CT scan the day after reduction to evaluate fracture alignment.
1 to 2 visits
Duration - Up to 3 weeks
Participants have follow-up X-rays at 6-8 days and possibly again within 3 weeks if slight redislocation is detected, to check if the fracture remains stable.
2 to 3 visits
Duration - 3 months
Participants undergo X-rays when the cast is removed (after 5 weeks) and a final X-ray at 3 months to assess fracture stability and healing.
2 visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
S A Earnshaw, A Aladin, S Surendran...
https://pubmed.ncbi.nlm.nih.gov/11886903/L M Hove, E Solheim, R Skjeie...
https://pubmed.ncbi.nlm.nih.gov/7706876/M McQueen, J Caspers
https://pubmed.ncbi.nlm.nih.gov/3403617/Mohammad Ali Tahririan, Mohammad Javdan, Mohammad Hadi Nouraei...
https://pubmed.ncbi.nlm.nih.gov/24497862/Rohit Arora, Markus Gabl, Stefanie Erhart...
https://pubmed.ncbi.nlm.nih.gov/23569689/Dylan L McCreary, Benjamin C Sandberg, Debra C Bohn...
https://pubmed.ncbi.nlm.nih.gov/30461316/Sondre Stafsnes Hassellund, John Håkon Williksen, Marit Mjelde Laane...
https://pubmed.ncbi.nlm.nih.gov/33517725/C A Selles, M A M Mulders, J Winkelhagen...
https://pubmed.ncbi.nlm.nih.gov/34314402/M Lutz, R Arora, D Krappinger...
https://pubmed.ncbi.nlm.nih.gov/21161253/James Leone, Mohit Bhandari, Anthony Adili...
https://pubmed.ncbi.nlm.nih.gov/14608466/Oslo University Hospital
Lead Sponsor
Bergesenstiftelsen
Collaborating Sponsor